Literature DB >> 26699153

Elucidation of the CO-Release Kinetics of CORM-A1 by Means of Vibrational Spectroscopy.

Moritz Klein1, Ute Neugebauer1,2, Michael Schmitt3, Jürgen Popp4,5,6.   

Abstract

CO-releasing molecules (CORMs) are developed for investigations of the interaction between the signaling molecule carbon monoxide (CO) and cells or tissue. Prior to their application these molecules must be fully characterized with respect to their CO-release mechanism. One widely used CORM for biological application is sodium boranocarbonate (CORM-A1), which shows pH-dependent CO liberation. The complete reaction mechanism of CORM-A1 is not fully understood yet. Therefore, in this contribution time-resolved gas-phase IR spectroscopy is used to monitor the headspace above decaying CORM-A1 solutions at four different pH values (5.8 to 7.4). Borane carbonyl is found as an intermediate in the gas phase, which is formed during CORM degradation and further decays to CO. Concentration profiles of a pseudoconsecutive first-order reaction are successfully fitted to specific band areas of the measured gas-phase spectra, and the rate constants are obtained. The production of borane carbonyl is strongly pH dependent (half-lives between 5 and 106 min), whereas the decay of borane carbonyl in the gas phase is nearly constant with a half-life of about 33 min. The ratio of liberated CO molecules per CORM-A1 is determined to be 0.91±0.09, and boric acid is identified as further end product.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CO-releasing molecules; IR spectroscopy; carbon monoxide; kinetics; reaction mechanisms

Year:  2016        PMID: 26699153     DOI: 10.1002/cphc.201501062

Source DB:  PubMed          Journal:  Chemphyschem        ISSN: 1439-4235            Impact factor:   3.102


  4 in total

Review 1.  "CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications.

Authors:  Xiaoxiao Yang; Wen Lu; Minjia Wang; Chalet Tan; Binghe Wang
Journal:  J Control Release       Date:  2021-09-02       Impact factor: 11.467

Review 2.  Carbon monoxide: An emerging therapy for acute kidney injury.

Authors:  Xiaoxiao Yang; Mark de Caestecker; Leo E Otterbein; Binghe Wang
Journal:  Med Res Rev       Date:  2019-12-09       Impact factor: 12.944

3.  The anticoagulant effect of Apis mellifera phospholipase A2 is inhibited by CORM-2 via a carbon monoxide-independent mechanism.

Authors:  Vance G Nielsen
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

4.  Carbon monoxide formation from trimethylamine-boranecarboxylate: DFT studies of SNi and chelotropic mechanisms.

Authors:  John W Keller; Theppawut I Ayudhya; Nin N Dingra
Journal:  RSC Adv       Date:  2020-04-24       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.